TargetTransient receptor potential cation channel subfamily V member 1(Homo sapiens (Human))
Medifron Dbt
US Patent
Medifron Dbt
US Patent
Affinity DataKi: 19.4nMAssay Description:The FLIPR protocol consists of 2 substance additions during a kinetic measurement. First the compounds to be tested (5 μM) are pipetted onto the...More data for this Ligand-Target Pair